IRCT20141016019554N13已完成3 期
Comparing the effect of sevelamer carbonate and sevelamer hydrochloride on blood level of phosphate, Ca, ph, bicarbonate and gastrointestinal complications in patients undergoing maintenance hemodialysis
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit(—)
- 性别
- All
入选标准
- •Patients who undergo dialysis three sessions each week for four hours each day.
- •Their blood phosphorus level is higher than 5.5 mg / dL.
排除标准
- •Patients who have not taken limited Phosphorus diet.
- •Patients who lose their ability to participate during the study
- •Patients who are absent from dialysis session
- •Patients who break their access for some reason
- •Patients who have taken the medication inappropriately.
- •Patients with a history of primary hyperparathyroidism or history of parathyroidectomy.
- •Patients with a history of gastrointestinal diseases include peptic ulcer, reflux, and constipation
- •Patients with a history of congestive heart failure (due to electrolyte imbalance)
- •Patients with chronic obstructive pulmonary disease (COPD) (due to acid and basis disorders).
研究者
相似试验
已完成
3 期
Powdered phosphate lowering medicine for Indian patients on hemodialysis.CTRI/2015/11/006342emcure pharmaceuticals50
已完成
3 期
Comparison of Sevelamer and Calcium carbonat on magnesium serum level in hemodialyzed patientsIRCT20180831040912N1Semnan University of Medical Sciences60
已完成
4 期
Comparing the Effect of Sevelamer Hydrochloride and Calcium Carbonate on Serum Level of Inflammatory Markers in Hemodialysis PatientsIRCT20200724048193N1Tabriz University of Medical Sciences40
招募中
2 期
Evaluation the effect of adding Sevelamer to the standard treatment of aluminum phosphide poisoning patientsIRCT20210720051946N7Shahid Beheshti University of Medical Sciences60
尚未招募
不适用
Comparison of Ferric Citrate and Sevelamer in the treatment of high phosphate level in patients with Chronic Kidney DiseaseCTRI/2021/11/037748il
